{
  "title": "Medications Under Investigation for BPD",
  "itunes:title": "Medications Under Investigation for BPD",
  "pubDate": "Thu, 21 Jul 2022 16:00:19 +0000",
  "guid": "0420ef08-87c8-467d-85de-e869e1c2a97a",
  "link": "https://psychopharmacology.libsyn.com/medications-under-investigation-for-bpd",
  "itunes:image": "",
  "description": "<p>What other medications can we offer to our patients with BPD? This episode discusses some novel medication approaches used in borderline personality disorder, including omega-3 fatty acids, methylphenidate, clonidine, doxazosin, memantine, and oxytocin. </p> <p>Faculty: Paul Links, M.D. <br /> Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC172\"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/pharmacologic-management-of-bpd-recent-developments-2633?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC172\"> <strong>Earn 0.5 CMEs: Pharmacologic Management of BPD: Recent Developments</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/omega-3-fatty-acids-methylphenidate-clonidine-doxazosin-memantine-and-oxytocin-for-bpd-2633-5143?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC172\"> <strong>Omega-3 Fatty Acids, Methylphenidate, Clonidine, Doxazosin, Memantine, and Oxytocin for BPD</strong></a></li> </ul>",
  "content:encoded": "<p>What other medications can we offer to our patients with BPD? This episode discusses some novel medication approaches used in borderline personality disorder, including omega-3 fatty acids, methylphenidate, clonidine, doxazosin, memantine, and oxytocin. </p> <p>Faculty: Paul Links, M.D.  Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC172\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/pharmacologic-management-of-bpd-recent-developments-2633?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC172\"> Earn 0.5 CMEs: Pharmacologic Management of BPD: Recent Developments</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/omega-3-fatty-acids-methylphenidate-clonidine-doxazosin-memantine-and-oxytocin-for-bpd-2633-5143?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC172\"> Omega-3 Fatty Acids, Methylphenidate, Clonidine, Doxazosin, Memantine, and Oxytocin for BPD</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "09:56",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "What other medications can we offer to our patients with BPD? This episode discusses some novel medication approaches used in borderline personality disorder, including omega-3 fatty acids, methylphenidate, clonidine, doxazosin, memantine, and...",
  "itunes:episodeType": "full"
}